No Benefit of Postoperative Dalteparin Bridging Treatment for Preventing Thromboembolism
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
BMJ : British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Postoperative Low Molecular Weight Heparin Bridging Treatment for Patients at High Risk of Arterial Thromboembolism (PERIOP2): Double Blind Randomised Controlled Trial
BMJ 2021 Jun 09;[EPub Ahead of Print], MJ Kovacs, PS Wells, DR Anderson, A Lazo-Langner, C Kearon, SM Bates, M Blostein, SR Kahn, S Schulman, E Sabri, S Solymoss, T Ramsay, E Yeo, MA RodgerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.